Piramal Pharma Ltd has emerged as a top gainer in the Indian stock market, driven by its robust performance and strategic positioning in the global pharmaceutical landscape, amidst market volatility.

Piramal Pharma Ltd. has announced a $90 million investment to expand its U.S. operations, enhancing two facilities and strengthening its presence in the American market.